This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Jazz Pharmaceuticals Ireland Limited. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Nicolas Emmanuel Stephane Guisot: Innovator in Cancer Treatment
Introduction
Nicolas Emmanuel Stephane Guisot is a notable inventor based in Macclesfield, GB. He has made significant contributions to the field of medical research, particularly in the development of treatments for cancer. His innovative work has led to the creation of a patent that addresses critical health challenges.
Latest Patents
Guisot holds a patent for "RAS inhibitors and methods of using the same." This patent includes compounds identified as inhibitors of KRAS protein activity, which can be utilized to treat various diseases and disorders, including cancer. His work in this area is crucial for advancing therapeutic options for patients.
Career Highlights
Guisot is associated with Jazz Pharmaceuticals Ireland Limited, where he applies his expertise in pharmaceutical research and development. His role at the company allows him to contribute to innovative solutions in the healthcare sector.
Collaborations
Guisot has worked alongside notable colleagues, including Andrew Belfield and Clifford David Jones. Their collaborative efforts have furthered research and development in the field of cancer treatment.
Conclusion
Nicolas Emmanuel Stephane Guisot is a dedicated inventor whose work in developing RAS inhibitors represents a significant advancement in cancer treatment. His contributions to medical research continue to impact the lives of many patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile